Registration, storage and distribution of chemicals and drugs for pre-clinical discovery evaluation and development
Ended Awarded Last action
- Contract number
- 75N91021F00001
- Awardee
-
Fisher Bioservices Inc. UEI LB4PCGLSJ9E6 Part of Thermo Electron Corporation
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,278,919
Award facts
- Opportunity
-
- 2021CAR01 Solicitation number
- Contract value 100% obligated
- $5,278,918.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $2,557,740 | |
| Original award | $2,721,179 |
About this award
The National Institutes of Health National Cancer Institute awarded a $5.3 million delivery order contract to Fisher Bioservices Clinical Trials Division for the registration, storage, and distribution of chemicals and drugs in support of pre-clinical discovery, evaluation, and development efforts. Under the cost-plus-fixed-fee contract running from March 2021 through February 2023, Fisher Bioservices will provide services for the handling and management of chemicals and compounds as the NIH seeks to advance cancer research. As a division of Thermo Electron Corporation's Financial Services, Fisher Bioservices leverages specialized expertise and facilities to safely and effectively support the NIH's drug development pipeline from pre-clinical stages through to clinical trials.
Quick answers
Who was awarded contract 75N91021F00001?
75N91021F00001 was awarded to Fisher Bioservices Inc. by National Cancer Institute (National Institutes of Health) on March 1, 2021.
How much is contract 75N91021F00001 worth?
The government has obligated $5,278,919 on 75N91021F00001.
Is contract 75N91021F00001 an order under another contract?
Yes. 75N91021F00001 is a delivery order under HHSN261201600006I, an indefinite delivery contract.
Was contract 75N91021F00001 competed?
The extent of competition for 75N91021F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award